Project Grant R43DC023164
- The National Institute on Deafness and Other Communication Disorders awarded Cognixion Corporation $1,258,551 on July 20, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop and clinically validate the Cognixion Axon-R, a wearable augmented reality and brain-computer interface device combined with generative AI software for restoring communication in individuals with amyotrophic lateral sclerosis and related neurodegenerative conditions....
- The National Institute on Deafness and Other Communication Disorders, part of the Department of Health and Human Services National Institutes of Health, awarded $132,695 to the University of Maryland, College Park on July 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop artificial intelligence methods for delivering vocal tract gesture biofeedback in speech sound disorder therapy for children. The work spans two phases through June...
- The National Institute on Deafness and Other Communication Disorders awarded the University of Texas at Austin $160,879 on September 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop and validate a wearable silent speech interface for laryngectomees. The project delivers two intraoral wireless tongue-tracking devices—MAGTRACK, a glasses-like wearable with a wired tongue sensor, and WITT, a wireless and intraoral device—both integrated...
- The National Institute on Deafness and Other Communication Disorders awarded Micro-Leads Inc. $1.486 million on August 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop a closed-loop electrical stimulation therapy for unilateral vocal fold paralysis that restores natural voice and swallowing function. Micro-Leads will design and develop a closed-loop laryngeal electrical stimulation system that detects and responds to physiological needs...
- The National Institute on Deafness and Other Communication Disorders awarded Auspex Medix, LLC $305,923 on July 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop SATE (Speech Annotation and Transcription Enhancer), an AI-powered platform that automates language sample analysis for speech-language pathologists. SATE automates multi-layer linguistic annotation across word- and phoneme-level transcription, C-unit segmentation, phonetic...
- The National Institute on Deafness and Other Communication Disorders awarded Glimpse Diagnostics, Inc. $314,258 on June 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop closed-loop control algorithms for an adaptive Eustachian tube dysfunction treatment device. The recipient will create Bayesian optimization algorithms and computational fluid dynamics modeling to enable a point-of-care device that uses masseter reflex stimulation to...
- The National Institute on Deafness and Other Communication Disorders awarded Northwestern University $690,331 on August 25, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop personalized brain-computer interfaces for decoding language in people with nonfluent aphasia. The research addresses a critical gap in BCI technology. Nearly all existing speech BCIs decode signals from the frontal lobe, which is typically damaged in nonfluent...
- The National Institute on Deafness and Other Communication Disorders awarded Young TECH Solutions LLC $313,354 on July 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop Young Speaker, an iOS-compatible software platform for minimally verbal children with autism spectrum disorder. Young Speaker combines video modeling and augmentative and alternative communication into a unified workflow that enables caregivers to create personalized...
- The National Institute on Deafness and Other Communication Disorders awarded The University of Chicago $451,000 on August 24, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop a native biochemical preparation of the mechanotransduction complex (METC) from cnidarian nematocytes as a model of vertebrate hair-cell function. The award funds research into the structural dynamics and functional mechanisms of the METC, the cellular machinery...
- The National Science Foundation Division of Computer and Network Systems awarded the University of Massachusetts $250,000 on August 15, 2026, under the Computer and Information Science and Engineering program (CFDA 47.070) to design a closed-loop unvoiced interaction paradigm enabling silent communication with computing devices. The project develops a sensor-equipped ear-worn device that detects jaw movement and facial vibrations associated with unvoiced speech, transforming these signals into...
The National Institute on Deafness and Other Communication Disorders awarded Augmental Technologies Inc. $329,475 on August 20, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to develop a novel intra-oral wearable device that integrates inaudible speech recognition with an existing tongue-based computer interface for users with cervical spinal cord injuries. Augmental has developed the MouthPad, a fully wireless intraoral device that enables cursor control via a tongue-based trackpad and head-based motion sensing, allowing users with hand impairments to operate laptops, smartphones, and other devices. This Phase I project will determine the feasibility of incorporating whisper speech recognition—speech too quiet to be heard by nearby listeners—into the MouthPad system to enhance digital device accessibility through language input. This approach addresses limitations of conventional speech-to-text technology, which produces correction errors that are laborious for quadriplegics to fix without hand dexterity, performs poorly in noisy environments, raises privacy concerns, and cannot reliably serve users with distorted or restricted voice use, a common occurrence in cervical spinal cord injury cases. Performance occurs in San Francisco, California. The period of performance runs through July 31, 2027. The assistance type is a Project Grant, which supports biomedical research and development including salaries, equipment, supplies, travel, and other allowable direct and indirect costs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $329.5k | 8/24/26 |